Methods and compounds of cannabidiol, melatonin and akba for treating pancreatic cancer
AssigneesIntegrative Therapy Discovery Lab S.R.L., Fondazione Maria Guarino Amor Onlus
InventorsCristina AGUZZI, Margherita LUONGO, Oliviero MARINELLI, Massimo NABISSI, Laura ZEPPA
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to the use of suitable compounds such as cannabidiol (CBD), melatonin (MLT), acetyl-11-keto-beta-boswellic acid (AKBA), or combinations thereof for treatment of pancreatic cancer and/or similar conditions, diseases or disorders.
Claims25
A method of treating a pancreatic cancer, comprising administering a combination of cannabidiol, melatonin, and AKBA to the subject in need thereof.
A method of treating a PC in a subject in need thereof, comprising administering an effective amount of at least one compound to the subject.
A composition for treating a pancreatic cancer, comprising cannabidiol, melatonin, and AKBA.
Dependencies are inferred from the claim text.